The plan calls for 45 thousand jobs at full buildout. Already there is a $10 Billion dollar annual economic impact in a single square mile….
Find out what's happening on campus and across the industry.
Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.
Ceria Therapeutics, Inc. Awarded a $300,000 SBIR Grant to Advance Development of a Novel Treatment of Non-Healing Diabetic Foot Ulcers
Ceria Therapeutics, Inc. (Ceria), a Colorado-based biotech startup focusing on the development of novel therapeutics to address several inflammatory diseases, today announced the company has received a second Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). This award is directed to development of CTX-001 for the treatment of non-healing diabetic foot ulcers (DFUs).
As the main gateway to a large research and clinical infrastructure, CU Innovations pairs industry partners with clinicians to create next-generation products that can ultimately reach patient care. Thanks to hospital partners at Children’s Hospital Colorado and the UCHealth system, CU Innovations has established a living clinical laboratory for testing and validating the best healthcare technologies.
The onset of the COVID-19 pandemic in early 2020 put a spotlight on the life sciences industry, yet in reality the sector was already quietly becoming a powerhouse, with Metro Denver emerging as a major player.
In a Q&A with Fitzsimons Innovation Community, Elyse Blazevich, Colorado BioScience Association President & CEO, offers her perspective on the biggest areas of growth for life sciences, the top trends she’s monitoring, and how the Association advocates for a supportive business climate in our state.